Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Mar-24 9:45 PM View:  | Novo A/s 10% Owner | Spruce Biosciences, Inc. (SPRB) | 21-Mar-24 | Sale | 465,021 | $0.75 | $350,951.00 | (15%) 3.02M to 2.55M | |
| 20-Mar-24 8:56 PM View: | Novo A/s 10% Owner | Spruce Biosciences, Inc. (SPRB) | 20-Mar-24 | Sale | 359,979 | $0.73 | $264,081.00 | (11%) 3.37M to 3.02M | |
| 20-Mar-24 8:56 PM View: | Novo A/s 10% Owner | Spruce Biosciences, Inc. (SPRB) | 19-Mar-24 | Sale | 593,000 | $0.75 | $447,715.00 | (15%) 3.97M to 3.38M | |
| 20-Mar-24 8:56 PM View: | Novo A/s 10% Owner | Spruce Biosciences, Inc. (SPRB) | 18-Mar-24 | Sale | 842,020 | $0.77 | $647,008.00 | (18%) 4.81M to 3.97M | |
| 18-Mar-24 9:14 PM View: | Novo A/s 10% Owner | Spruce Biosciences, Inc. (SPRB) | 14-Mar-24 | Sale | 1,912,320 | $0.89 | $1,698,900.00 | (28%) 6.72M to 4.81M | |
| 03-Jan-24 4:08 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 29-Dec-23 | Grant | 11,255 | $0.98 | $11,001.80 | 6% 191.52K to 202.78K | |
| 03-Jan-24 4:10 PM View: | Charlton Ralph William III Chief Medical Officer | Spruce Biosciences, Inc. (SPRB) | 29-Dec-23 | Grant | 9,361 | $0.98 | $9,150.38 | 20% 46.01K to 55.37K | |
| 18-Dec-23 8:15 PM View: | Szwarcberg Javier B. Chief Executive Officer Director | Spruce Biosciences, Inc. (SPRB) | 15-Dec-23 | Option Exercise | 111,000 | -- | -- | 320% 34.7K to 145.71K | |
| 18-Dec-23 8:16 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 15-Dec-23 | Payment of Exercise | 36,095 | $1.66 | $59,917.70 | (16%) 227.62K to 191.52K | |
| 18-Dec-23 8:17 PM View: | Charlton Ralph William III Chief Medical Officer | Spruce Biosciences, Inc. (SPRB) | 15-Dec-23 | Payment of Exercise | 10,980 | $1.66 | $18,226.80 | (19%) 56.99K to 46.01K | |
| 18-Dec-23 8:16 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 15-Dec-23 | Option Exercise | 112,250 | -- | -- | 97% 115.37K to 227.62K | |
| 18-Dec-23 8:15 PM View: | Szwarcberg Javier B. Chief Executive Officer Director | Spruce Biosciences, Inc. (SPRB) | 15-Dec-23 | Payment of Exercise | 38,384 | $1.66 | $63,717.40 | (26%) 145.71K to 107.32K | |
| 18-Dec-23 8:17 PM View: | Charlton Ralph William III Chief Medical Officer | Spruce Biosciences, Inc. (SPRB) | 15-Dec-23 | Option Exercise | 31,750 | -- | -- | 126% 25.24K to 56.99K | |
| 05-Jul-23 6:00 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 30-Jun-23 | Payment of Exercise | 25,936 | $2.15 | $55,762.40 | (18%) 141.3K to 115.37K | |
| 05-Jul-23 6:00 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 30-Jun-23 | Grant | 10,484 | $0.98 | $10,248.10 | 19% 55.82K to 66.3K | |
| 05-Jul-23 6:01 PM View: | Szwarcberg Javier B. Chief Executive Officer Director | Spruce Biosciences, Inc. (SPRB) | 30-Jun-23 | Grant | 20,000 | $0.98 | $19,550.00 | 136% 14.71K to 34.7K | |
| 05-Jul-23 6:00 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 30-Jun-23 | Option Exercise | 75,000 | -- | -- | 113% 66.3K to 141.3K | |
| 05-Jul-23 6:03 PM View: | Charlton Ralph William III Chief Medical Officer | Spruce Biosciences, Inc. (SPRB) | 30-Jun-23 | Grant | 12,378 | $0.98 | $12,099.50 | 96% 12.86K to 25.24K | |
| 21-Feb-23 4:19 PM View: | Novo A/s 10% Owner | Spruce Biosciences, Inc. (SPRB) | 16-Feb-23 | Private Purchase | 2,208,000 | $3.17 | $6,999,360.00 | 49% 4.51M to 6.72M | |
| 16-May-23 4:08 PM View: | O'Donnell Niall Director | Spruce Biosciences, Inc. (SPRB) | 16-Feb-23 | Private Purchase | 630,400 | $3.17 | $1,998,370.00 | 91% 695.9K to 1.33M | |
| 05-Jan-23 10:00 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 03-Jan-23 | Option Exercise | 37,500 | -- | -- | 112% 33.61K to 71.11K | |
| 05-Jan-23 10:00 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 03-Jan-23 | Payment of Exercise | 15,293 | $1.15 | $17,586.90 | (22%) 71.11K to 55.82K | |
| 05-Jan-23 10:00 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 30-Dec-22 | Grant | 1 | $0.93 | $0.93 | < 1% 33.61K to 33.61K | |
| 05-Jan-23 10:00 PM View: | Szwarcberg Javier B. Chief Executive Officer Director | Spruce Biosciences, Inc. (SPRB) | 30-Dec-22 | Grant | 14,705 | $0.93 | $13,716.80 | 100% 0 to 14.71K | |
| 05-Jan-23 10:00 PM View: | Charlton Ralph William III Chief Medical Officer | Spruce Biosciences, Inc. (SPRB) | 30-Dec-22 | Grant | 12,864 | $0.93 | $11,999.50 | 100% 0 to 12.86K | |
| 05-Jul-22 4:04 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 30-Jun-22 | Grant | 5,446 | $1.48 | $8,054.63 | 150% 3.63K to 9.08K | |
| 05-Jul-22 4:04 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 30-Jun-22 | Option Exercise | 37,500 | -- | -- | 413% 9.08K to 46.58K | |
| 05-Jul-22 4:04 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 30-Jun-22 | Payment of Exercise | 12,968 | $1.74 | $22,564.30 | (28%) 46.58K to 33.61K | |
| 05-Jan-22 4:00 PM View: | Gharib Samir M. President & CFO | Spruce Biosciences, Inc. (SPRB) | 31-Dec-21 | Acquisition (other) | 2,220 | $3.79 | $8,416.02 | 92% 2.41K to 4.63K | |
| 06-Jul-21 4:11 PM View: | Gharib Samir M. Chief Financial Officer | Spruce Biosciences, Inc. (SPRB) | 30-Jun-21 | Acquisition (other) | 1,412 | $9.53 | $13,454.20 | 100% 0 to 1.41K | |
| 06-Jul-21 4:12 PM View: | King Richard Chief Executive Officer Director | Spruce Biosciences, Inc. (SPRB) | 30-Jun-21 | Acquisition (other) | 2,230 | $9.53 | $21,248.60 | 100% 0 to 2.23K | |
| 21-May-21 9:10 PM View: | Simpson Camilla V Director | Spruce Biosciences, Inc. (SPRB) | 20-May-21 | Option Exercise | 334 | $0.85 | $283.90 | 100% 0 to 0.33K | |
| 21-May-21 9:10 PM View: | Simpson Camilla V Director | Spruce Biosciences, Inc. (SPRB) | 20-May-21 | Market Option Sale (Planned) | 334 | $15.29 | $5,106.86 | (100%) 0.33K to 0 | |
| 21-May-21 4:32 PM View: | Novo A/s 10% Owner | Spruce Biosciences, Inc. (SPRB) | 19-May-21 | Market Sale | 475,000 | $13.90 | $6,602,500.00 | (10%) 4.99M to 4.51M | (10%) |
| 04-May-21 9:09 PM View: | Simpson Camilla V Director | Spruce Biosciences, Inc. (SPRB) | 30-Apr-21 | Market Option Sale (Planned) | 14,045 | $16.14 | $226,664.00 | (100%) 14.04K to 0 | |
| 04-May-21 9:09 PM View: | Simpson Camilla V Director | Spruce Biosciences, Inc. (SPRB) | 30-Apr-21 | Option Exercise | 14,045 | $0.85 | $11,938.20 | 100% 0 to 14.04K | |
| 16-Oct-20 12:21 PM View: | O'Donnell Niall Director | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Conversion | 445,905 | -- | -- | 100% 0 to 445.9K | |
| 16-Oct-20 12:24 PM View: | Muralidhar Bali Director | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Conversion | 1,592,520 | -- | -- | 100% 0 to 1.59M | |
| 16-Oct-20 4:49 PM View: | Novo A/s 10% Owner | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Conversion | 4,739,340 | -- | -- | 100% 0 to 4.74M | |
| 16-Oct-20 12:08 PM View: | Healthcap Viii, L.P. | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Conversion | 1,783,620 | -- | -- | 100% 0 to 1.78M | |
| 16-Oct-20 12:15 PM View: | Omega Fund Vi, L.P. | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Purchase | 250,000 | $15.00 | $3,750,000.00 | 13% 1.91M to 2.16M | |
| 16-Oct-20 12:34 PM View: | Rivervest Venture Fund Iii,... 10% Owner | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Conversion | 1,898,280 | -- | -- | 64% 2.97M to 4.87M | |
| 16-Oct-20 12:21 PM View: | O'Donnell Niall Director | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Purchase Duplicate | 250,000 | $15.00 | $3,750,000.00 | 56% 445.9K to 695.9K | |
| 16-Oct-20 12:07 PM View: | Hansson Jonas Director | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Conversion Duplicate | 1,783,620 | -- | -- | 100% 0 to 1.78M | |
| 16-Oct-20 12:14 PM View: | Chaya Moghrabi Dina Director | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Conversion Duplicate | 1,911,020 | -- | -- | 100% 1.91M to 3.82M | |
| 16-Oct-20 12:24 PM View: | Muralidhar Bali Director | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Purchase | 200,000 | $15.00 | $3,000,000.00 | 13% 1.59M to 1.79M | |
| 16-Oct-20 4:49 PM View: | Novo A/s 10% Owner | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Purchase | 250,000 | $15.00 | $3,750,000.00 | 5% 4.74M to 4.99M | |
| 16-Oct-20 12:08 PM View: | Healthcap Viii, L.P. | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Purchase | 250,000 | $15.00 | $3,750,000.00 | 14% 1.78M to 2.03M | |
| 16-Oct-20 12:34 PM View: | Rivervest Venture Fund Iii,... 10% Owner | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Purchase Duplicate | 250,000 | $15.00 | $3,750,000.00 | 5% 4.87M to 5.12M | |
| 16-Oct-20 12:07 PM View: | Hansson Jonas Director | Spruce Biosciences, Inc. (SPRB) | 14-Oct-20 | Purchase Duplicate | 250,000 | $15.00 | $3,750,000.00 | 14% 1.78M to 2.03M |
